Zentalis Pharmaceuticals
ZNTL
ZNTL
145 hedge funds and large institutions have $314M invested in Zentalis Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 42 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
12.23% less ownership
Funds ownership: 120.2% → 107.96% (-12%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
77% less capital invested
Capital invested by funds: $1.34B → $314M (-$1.03B)
Holders
145
Holding in Top 10
2
Calls
$262K
Puts
$48K
Top Buyers
| 1 | +$5.14M | |
| 2 | +$3.97M | |
| 3 | +$3.74M | |
| 4 |
Two Sigma Investments
New York
|
+$3.3M |
| 5 |
Two Sigma Advisers
New York
|
+$2.85M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$12.4M | |
| 3 | -$10.5M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$8.77M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$8.15M |